Isothermal, in Vitro Amplification of Nucleic Acids by a Multienzyme

Total Page:16

File Type:pdf, Size:1020Kb

Isothermal, in Vitro Amplification of Nucleic Acids by a Multienzyme Proc. Natl. Acad. Sci. USA Vol. 87, pp. 1874-1878, March 1990 Biochemistry Isothermal, in vitro amplification of nucleic acids by a multienzyme reaction modeled after retroviral replication (reverse transcriptase/RNase H/T7 RNA polymerase) JOHN C. GUATELLI*t, KRISTINA M. WHITFIELDt, DEBORAH Y. KWOHt, KEVIN J. BARRINGERt, DOUGLAS D. RICHMAN*t, AND THOMAS R. GINGERASO§ *Departments of Medicine and Pathology, University of California San Diego School of Medicine, and tSan Diego Veterans Administration Medical Center, San Diego, CA 92161; and tThe Salk Institute Biotechnology/Industrial Associates, Inc., La Jolla, CA 92037 Communicated by Ronald M. Evans, December 18, 1989 (receivedfor review October 6, 1989) ABSTRACT A target nucleic acid sequence can be repli- RNA Purification. Human immunodeficiency virus type 1 cated (amplified) exponentially in vitro under isothermal con- (HIV-1) RNA was extracted in total RNA from HIV- ditions by using three enzymatic activities essential to retroviral 1-infected CEM cells by the guanidinium isothiocyanate/ replication: reverse transcriptase, RNase H, and a DNA- cesium chloride gradient procedure (6) and quantitated by dependent RNA polymerase. By mimickisg the retroviral comparative hybridization to standards of known concentra- strategy of RNA replication by means of cDNA intermediates, tion. this reaction accumulates cDNA and RNA copies ofthe original 3SR Reaction. One hundred-microliter 3SR amplification target. Product accumulation is exponential with respect to reactions contained the target RNA, 40 mM Tris-HCI at pH time, indicating that newly synthesized cDNAs and RNAs 8.1, 20 mM MgCl2, 25 mM NaCl, 2 mM spermidine hydro- function as templates for a continuous series of transcription chloride, 5 mM dithiothreitol, bovine serum albumin (80 and reverse transcription reactions. Ten million-fold amplifi- ,ug/ml), 1 mM dATP, 1 mM dCTP, 1 mM dGTP, 1 mM dTTP, cation occurs after a 1- to 2-hr incubation, with an initial rate 4 mM ATP, 4 mM CTP, 4 mM GTP, 4 mM UTP, 250 ng of of amplification of 10-fold every 2.5 min. This self-sustained oligonucleotide 88-211 (primer B, 5'-AATTTAATACGACT- sequence replication system is useful for the detection and CACTATAGGGATCTATTGTGCCCCGGCTGGTTTTGC- nucleotide sequence analysis of rare RNAs and DNAs. The GATTCTA-3'), and 250 ng ofoligonucleotide 88-347 (primer analogy to aspects of retroviral replication is discussed. A, 5'-AATTTAATACGACTCACTATAGGGATGTACTAT- TATGGTTTTAGCATTGTCTAGTGA-3'). [Each priming The transfer of genetic information from RNA to DNA and oligonucleotide contains the T7 RNA polymerase binding then back to RNA is a scheme characteristic ofretroviruses. sequence (italic) and the preferred transcriptional initiation Such a scheme provides a mechanism for the replication of site (boldface). The remaining sequence is complementary to RNA genomes (reviewed in refs. 1-3). In exploring variations the target HIV-1 sequence.] After heating at 650C for 1 min ofan in vitro transcription-based amplification system (TAS) and cooling at 370C for 2 min, 30 units of AMV reverse (4), it was discovered that it was possible to devise a transcriptase, 100 units of T7 RNA polymerase, and 4 units concerted, three-enzyme, in vitro reaction to carry out an ofE. coliRNase H were added to each reaction. All reactions isothermal replication oftarget nucleic acid sequences, anal- were incubated at 370C for 1 hr or the amount of time ogous to the strategy used in retroviral replication. This indicated and stopped by placing the reaction on ice. reaction is a self-sustained sequence replication (3SR) system Bead-Based Sandwich Hybridization. The 3SR amplifica- involving the collective activities of avian myeloblastosis tion product and 32P-labeled oligonucleotide 87-81 (5'- virus (AMV) reverse transcriptase, Escherichia coli RNase AATTAGGCCAGTAGTATCAACTCAACT-3') were dena- RNA tured in 30 ttl of 10 mM Tris, pH 8.1/1 mM EDTA at 650C for H, and T7 polymerase. The accumulation ofboth target 5 min in an Eppendorf tube. To this, 30 ul of a solution nucleic acid-specific RNA and cDNA has been observed, hybridization mixture [10x standard saline phosphate/EDTA quantitated, and characterized. Several aspects of this 3SR (6)10%o (wt/vol) dextran sulfate/0.2% SDS] was added. The amplification protocol provide features not observed in the solution was mixed and incubated at 420C for 2 hr. use ofeither the polymerase chain reaction or TAS protocols. Approximately 25 mg (wet weight) of Trisacryl beads These features and the parallels between the strategies em- containing oligonucleotide 86-273 (5'-AGTCTAGCAGAA- ployed in the 3SR reaction and during retroviral replication GAAGAGGTAGTAATTAGA-3') was prehybridized in 250 are noted and discussed. pA of hybridization solution (5 x standard saline phosphate/ EDTA/10% dextran sulfate/0.1% SDS) in a 2-ml microcol- MATERIALS AND METHODS umn (Isolab) for 30 min at 370C. The prehybridization solu- tion was removed, and 40 p.1 of fresh hybridization solution Materials. AMV reverse transcriptase was purchased from was added to the beads, together with the 60 p.1 of solution Life Sciences (Saint Petersburg, FL); T7 RNA polymerase from the solution hybridization step. The beads were then was from Stratagene; E. coliRNase H and RNase-free DNase incubated at 370C for 1 hr with occasional mixing and then I were from Bethesda Research Laboratories. Oligonucleo- washed six times with 1 ml of 2x standard saline citrate (6) tides were synthesized by phosphoramidate chemistry by at 370C. The radioactivity of the beads and the combined using an Applied Biosystems model 380A DNA synthesizer. washes was measured by Cerenkov counting for 1 min. The Trisacryl beads containing capture oligonucleotides, which amount of target detected was determined by calculating the were used for sandwich hybridizations, were prepared sim- percentage of total radioactivity captured on the beads and ilarly to those described previously (5). Abbreviations: 3SR, self-sustained sequence replication; TAS, tran- The publication costs of this article were defrayed in part by page charge scription-based amplification system; HIV-1, human immunodefi- payment. This article must therefore be hereby marked "advertisement" ciency virus type 1; AMV, avian myeloblastosis virus. in accordance with 18 U.S.C. §1734 solely to indicate this fact. §To whom reprint requests should be addressed. 1874 Downloaded by guest on October 2, 2021 Biochemistry: Guatefli et al. Proc. Natl. Acad. Sci. USA 87 (1990) 1875 then multiplying this percentage by the femtomoles of 32P- Step 1 5' 3'RNA labeled oligonucleotides used for the hybridization. 3 primer 2 I3) RNA Nuclease Digestion. Samples of 3SR reactions were di- 5' t gested with RNase-free DNase I in 50 mM sodium acetate at 4RT DNA pH 6.5, 10 mM MgCl2, and 2 mM CaC12 in the presence of 3 5' | >'RNA ___ RNaseA, H DNA enzyme (25 pug/ml) at 370C for 1 hr. Digestions were termi- 4 RNA nated by the addition of EDTA to 12.5 mM and were - %rie DNA ~ DNA extracted once with an equal volume of phenol/chloroform 5 prior to separation in a 5% denaturing polyacrylamide gel. 3' |T DNA Direct 3SR Transcript Sequencing. One hundred-microliter 6 3m+ DNA 1100 DNA 3SR reactions were extracted once with an equal volume of T7RNA polymerase phenol/chloroform, adjusted to 0.3 M sodium acetate, and __3' 5' precipitated with the addition of 2.5 volumes of 100o etha- RNA (sense) RNA (anbsense) |3primer® 5' primer® nol. The reaction products were pelleted at 16,000 x g for 10 8 RNA ® ( DNA min, rinsed with 70%o (vol/vol) ethanol, and dried completely R- DNA RNA before being dissolved in 50 of sterile H20. Two percent A.l 9T ARNA - DNA of the transcript (derived from a 107-fold amplification from - DNA RNA 100 amol of target HIV) was sequenced (7) by using a primer RNase H RNase H complementary to the major antisense 3SR RNA product and 10 "'sa- RNA - DNA DNA Adoa oooRNA located within the targeted env region (5'-GACGTTCAATG- |'primer® Tprimer ) GAAC-3'). cDNA Cloning and Sequencing. The 3SR reactions were -DNA - DNA extracted once with phenol/chloroform, precipitated with 9 ADNA ethanol, and converted into first- and second-strand cDNAs -DNA by the single-tube method first described by D'Alessio and FIG. 1. Strategy of the 3SR scheme. The 3SR reaction depends Gerard (8). The second-strand synthesis reaction was termi- on a continuous cycle of reverse transcription and transcription nated by heating, and the cDNA ends were repaired by the reactions to replicate an RNA target by means of cDNA intermedi- direct addition of20 units ofthe large fragment ofE. coli DNA ates. Oligonucleotides A and B prime DNA synthesis and encode the polymerase I, followed by a 1.5-hr incubation at 22°C. promoter sequence for the T7 RNA polymerase (black boxes). Steps End-repaired cDNAs were extracted once with one volume 1-6 depict the synthesis of a double-stranded cDNA, which is a of phenol/chloroform and- then precipitated (in the presence transcription template for 17 RNA polymerase. Complete cDNA of 10 ,g of glycogen as a carrier) with 3 volumes of 100%o synthesis is dependent on the digestion of the RNA in the interme- ethanol. Precipitated cDNAs were phosphorylated with T4 diate RNA*DNA hybrid (step 4) by RNase H. Transcription- kinase into that had been competent cDNAs yield antisense RNA copies ofthe original target polynucleotide (6), ligated pUC19 (step 7, right). These transcripts are converted to cDNAs containing cut with Sma I and treated with phosphatase, and used to double-stranded promoters on both ends in an inverted repeat transform E. coli strain MC1061. 3SR clone-containing trans- orientation (steps 7-12). These cDNAs can yield either sense or formants were identified by colony hybridization by using a antisense RNAs, which can reenter the cycle. Thin lines, RNA; thick kinased oligonucleotide probe.
Recommended publications
  • Restriction Endonucleases
    Molecular Biology Problem Solver: A Laboratory Guide. Edited by Alan S. Gerstein Copyright © 2001 by Wiley-Liss, Inc. ISBNs: 0-471-37972-7 (Paper); 0-471-22390-5 (Electronic) 9 Restriction Endonucleases Derek Robinson, Paul R. Walsh, and Joseph A. Bonventre Background Information . 226 Which Restriction Enzymes Are Commercially Available? . 226 Why Are Some Enzymes More Expensive Than Others? . 227 What Can You Do to Reduce the Cost of Working with Restriction Enzymes? . 228 If You Could Select among Several Restriction Enzymes for Your Application, What Criteria Should You Consider to Make the Most Appropriate Choice? . 229 What Are the General Properties of Restriction Endonucleases? . 232 What Insight Is Provided by a Restriction Enzyme’s Quality Control Data? . 233 How Stable Are Restriction Enzymes? . 236 How Stable Are Diluted Restriction Enzymes? . 236 Simple Digests . 236 How Should You Set up a Simple Restriction Digest? . 236 Is It Wise to Modify the Suggested Reaction Conditions? . 237 Complex Restriction Digestions . 239 How Can a Substrate Affect the Restriction Digest? . 239 Should You Alter the Reaction Volume and DNA Concentration? . 241 Double Digests: Simultaneous or Sequential? . 242 225 Genomic Digests . 244 When Preparing Genomic DNA for Southern Blotting, How Can You Determine If Complete Digestion Has Been Obtained? . 244 What Are Your Options If You Must Create Additional Rare or Unique Restriction Sites? . 247 Troubleshooting . 255 What Can Cause a Simple Restriction Digest to Fail? . 255 The Volume of Enzyme in the Vial Appears Very Low. Did Leakage Occur during Shipment? . 259 The Enzyme Shipment Sat on the Shipping Dock for Two Days.
    [Show full text]
  • Phosphate Steering by Flap Endonuclease 1 Promotes 50-flap Specificity and Incision to Prevent Genome Instability
    ARTICLE Received 18 Jan 2017 | Accepted 5 May 2017 | Published 27 Jun 2017 DOI: 10.1038/ncomms15855 OPEN Phosphate steering by Flap Endonuclease 1 promotes 50-flap specificity and incision to prevent genome instability Susan E. Tsutakawa1,*, Mark J. Thompson2,*, Andrew S. Arvai3,*, Alexander J. Neil4,*, Steven J. Shaw2, Sana I. Algasaier2, Jane C. Kim4, L. David Finger2, Emma Jardine2, Victoria J.B. Gotham2, Altaf H. Sarker5, Mai Z. Her1, Fahad Rashid6, Samir M. Hamdan6, Sergei M. Mirkin4, Jane A. Grasby2 & John A. Tainer1,7 DNA replication and repair enzyme Flap Endonuclease 1 (FEN1) is vital for genome integrity, and FEN1 mutations arise in multiple cancers. FEN1 precisely cleaves single-stranded (ss) 50-flaps one nucleotide into duplex (ds) DNA. Yet, how FEN1 selects for but does not incise the ss 50-flap was enigmatic. Here we combine crystallographic, biochemical and genetic analyses to show that two dsDNA binding sites set the 50polarity and to reveal unexpected control of the DNA phosphodiester backbone by electrostatic interactions. Via ‘phosphate steering’, basic residues energetically steer an inverted ss 50-flap through a gateway over FEN1’s active site and shift dsDNA for catalysis. Mutations of these residues cause an 18,000-fold reduction in catalytic rate in vitro and large-scale trinucleotide (GAA)n repeat expansions in vivo, implying failed phosphate-steering promotes an unanticipated lagging-strand template-switch mechanism during replication. Thus, phosphate steering is an unappreciated FEN1 function that enforces 50-flap specificity and catalysis, preventing genomic instability. 1 Molecular Biophysics and Integrated Bioimaging, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA.
    [Show full text]
  • Anti-Dicer (SAB4200087)
    Anti-Dicer produced in rabbit, affinity isolated antibody Product Number SAB4200087 Product Description Precautions and Disclaimer Anti-Dicer is produced in rabbit using as the For R&D use only. Not for drug, household, or other immunogen a synthetic peptide corresponding to a uses. Please consult the Safety Data Sheet for fragment of human Dicer (Gene ID: 23405) conjugated information regarding hazards and safe handling to KLH. The corresponding sequence is identical in practices. mouse. The antibody is affinity-purified using the immunizing peptide immobilized on agarose. Storage/Stability Store at –20 C. For continuous use, store at 2–8 C for Anti-Dicer recognizes human Dicer. The antibody may up to one month. For extended storage, freeze in be used in several immunochemical techniques working aliquots at –20 C. Repeated freezing and including immunoblotting (218 kDa), immuno- thawing, or storage in “frost-free” freezers, is not precipitation, and immunofluorescence. Detection of recommended. If slight turbidity occurs upon prolonged the Dicer band by immunoblotting is specifically storage, clarify the solution by centrifugation before inhibited with the immunizing peptide. use. Working dilutions should be discarded if not used within 12 hours. Dicer, also known as Dicer1, Endoribonuclease Dicer, Helicase with RNase motif, and HERNA, is a member Product Profile of the RNase III family that catalyzes the first step in the Immunoblotting: a working antibody concentration of RNA interference (RNAi) pathway and initiates 3-6 g/mL is recommended using HeLa cell lysates. formation of the RNA-induced silencing complex (RISC). Dicer processes the dsRNA into small Immunoprecipitation: a working antibody amount of fragments called short interfering RNA (siRNA) or 2.5-5 g is recommended using HeLa cell lysates.
    [Show full text]
  • Type of the Paper (Article
    Supplementary Material A Proteomics Study on the Mechanism of Nutmeg-induced Hepatotoxicity Wei Xia 1, †, Zhipeng Cao 1, †, Xiaoyu Zhang 1 and Lina Gao 1,* 1 School of Forensic Medicine, China Medical University, Shenyang 110122, P. R. China; lessen- [email protected] (W.X.); [email protected] (Z.C.); [email protected] (X.Z.) † The authors contributed equally to this work. * Correspondence: [email protected] Figure S1. Table S1. Peptide fraction separation liquid chromatography elution gradient table. Time (min) Flow rate (mL/min) Mobile phase A (%) Mobile phase B (%) 0 1 97 3 10 1 95 5 30 1 80 20 48 1 60 40 50 1 50 50 53 1 30 70 54 1 0 100 1 Table 2. Liquid chromatography elution gradient table. Time (min) Flow rate (nL/min) Mobile phase A (%) Mobile phase B (%) 0 600 94 6 2 600 83 17 82 600 60 40 84 600 50 50 85 600 45 55 90 600 0 100 Table S3. The analysis parameter of Proteome Discoverer 2.2. Item Value Type of Quantification Reporter Quantification (TMT) Enzyme Trypsin Max.Missed Cleavage Sites 2 Precursor Mass Tolerance 10 ppm Fragment Mass Tolerance 0.02 Da Dynamic Modification Oxidation/+15.995 Da (M) and TMT /+229.163 Da (K,Y) N-Terminal Modification Acetyl/+42.011 Da (N-Terminal) and TMT /+229.163 Da (N-Terminal) Static Modification Carbamidomethyl/+57.021 Da (C) 2 Table S4. The DEPs between the low-dose group and the control group. Protein Gene Fold Change P value Trend mRNA H2-K1 0.380 0.010 down Glutamine synthetase 0.426 0.022 down Annexin Anxa6 0.447 0.032 down mRNA H2-D1 0.467 0.002 down Ribokinase Rbks 0.487 0.000
    [Show full text]
  • Structure and Function of Nucleases in DNA Repair: Shape, Grip and Blade of the DNA Scissors
    Oncogene (2002) 21, 9022 – 9032 ª 2002 Nature Publishing Group All rights reserved 0950 – 9232/02 $25.00 www.nature.com/onc Structure and function of nucleases in DNA repair: shape, grip and blade of the DNA scissors Tatsuya Nishino1 and Kosuke Morikawa*,1 1Department of Structural Biology, Biomolecular Engineering Research Institute (BERI), 6-2-3 Furuedai, Suita, Osaka 565-0874, Japan DNA nucleases catalyze the cleavage of phosphodiester mismatched nucleotides. They also recognize the bonds. These enzymes play crucial roles in various DNA replication or recombination intermediates to facilitate repair processes, which involve DNA replication, base the following reaction steps through the cleavage of excision repair, nucleotide excision repair, mismatch DNA strands (Table 1). repair, and double strand break repair. In recent years, Nucleases can be regarded as molecular scissors, new nucleases involved in various DNA repair processes which cleave phosphodiester bonds between the sugars have been reported, including the Mus81 : Mms4 (Eme1) and the phosphate moieties of DNA. They contain complex, which functions during the meiotic phase and conserved minimal motifs, which usually consist of the Artemis : DNA-PK complex, which processes a V(D)J acidic and basic residues forming the active site. recombination intermediate. Defects of these nucleases These active site residues coordinate catalytically cause genetic instability or severe immunodeficiency. essential divalent cations, such as magnesium, Thus, structural biology on various nuclease actions is calcium, manganese or zinc, as a cofactor. However, essential for the elucidation of the molecular mechanism the requirements for actual cleavage, such as the types of complex DNA repair machinery. Three-dimensional and the numbers of metals, are very complicated, but structural information of nucleases is also rapidly are not common among the nucleases.
    [Show full text]
  • Flap DNA Unwinding and Incision by the Human FAN1 Dimer
    ARTICLE Received 16 Aug 2014 | Accepted 30 Oct 2014 | Published 11 Dec 2014 DOI: 10.1038/ncomms6726 Structural insights into 50 flap DNA unwinding and incision by the human FAN1 dimer Qi Zhao1,*, Xiaoyu Xue1,*, Simonne Longerich1,*, Patrick Sung1 & Yong Xiong1 Human FANCD2-associated nuclease 1 (FAN1) is a DNA structure-specific nuclease involved in the processing of DNA interstrand crosslinks (ICLs). FAN1 maintains genomic stability and prevents tissue decline in multiple organs, yet it confers ICL-induced anti-cancer drug resistance in several cancer subtypes. Here we report three crystal structures of human FAN1 in complex with a 50 flap DNA substrate, showing that two FAN1 molecules form a head-to- tail dimer to locate the lesion, orient the DNA and unwind a 50 flap for subsequent incision. Biochemical experiments further validate our model for FAN1 action, as structure-informed mutations that disrupt protein dimerization, substrate orientation or flap unwinding impair the structure-specific nuclease activity. Our work elucidates essential aspects of FAN1-DNA lesion recognition and a unique mechanism of incision. These structural insights shed light on the cellular mechanisms underlying organ degeneration protection and cancer drug resistance mediated by FAN1. 1 Department of Molecular Biophysics and Biochemistry, Yale University School of Medicine, New Haven, Connecticut 06520, USA. * These authors contributed equally to this work. Correspondence and requests for materials should be addressed to P.S. (email: [email protected]) or to Y.X. (email: [email protected]). NATURE COMMUNICATIONS | 5:5726 | DOI: 10.1038/ncomms6726 | www.nature.com/naturecommunications 1 & 2014 Macmillan Publishers Limited. All rights reserved.
    [Show full text]
  • DICER1 Gene Dicer 1, Ribonuclease III
    DICER1 gene dicer 1, ribonuclease III Normal Function The DICER1 gene provides instructions for making a protein that plays a role in regulating the activity (expression) of other genes. The Dicer protein aids in the production of a molecule called microRNA (miRNA). MicroRNAs are short lengths of RNA, a chemical cousin of DNA. Dicer cuts (cleaves) precursor RNA molecules to produce miRNA. MicroRNAs control gene expression by blocking the process of protein production. In the first step of making a protein from a gene, another type of RNA called messenger RNA (mRNA) is formed and acts as the blueprint for protein production. MicroRNAs attach to specific mRNA molecules and stop the process by which protein is made. Sometimes, miRNAs break down the mRNA, which also blocks protein production. Through this role in regulating the expression of genes, Dicer is involved in many processes, including cell growth and division (proliferation) and the maturation of cells to take on specialized functions (differentiation). Health Conditions Related to Genetic Changes DICER1 syndrome Mutations in the DICER1 gene cause DICER1 syndrome. People with this condition have an increased risk of developing many types of tumors, particularly certain tumors of the lungs (pleuropulmonary blastoma); kidneys (cystic nephroma); ovaries (Sertoli- Leydig tumors); and thyroid, a butterfly-shaped gland in the lower neck (multinodular goiter). Most of these mutations lead to an abnormally short Dicer protein that is likely unable to produce miRNA. Without regulation by
    [Show full text]
  • Datasheet for Exonuclease V (Recbcd)
    Source: An E. coli strain containing plasmids Unit Assay Conditions: 1X NEBuffer 4, 1 mM ATP Physical Purity: Purified to > 95% homogene- Exonuclease V for expressing the three subunits of E. coli with 0.15 mM sonicated duplex [3H]-DNA. ity as determined by SDS-PAGE analysis using Exonuclease V: RecB, RecC and RecD. Coomassie Blue detection. (RecBCD) Heat Inactivation: 70°C for 30 minutes. Supplied in: 100 mM NaCl, 50 mM Tris-HCl A Typical Exonuclease V Reaction: 1-800-632-7799 (pH 7.5 @ 25°C), 0.1 mM EDTA, 1 mM DTT, Quality Control Assays x µl sample DNA (~ 1 µg) [email protected] 0.1% Triton X-100 and 50% glycerol. 3 µl NEBuffer4 (10X) www.neb.com Endonuclease Activity I: Incubation of a 50 µl 3 µl 10 mM ATP M0345S 001121014101 reaction containing 100 units of Exonuclease V Reagents Supplied with Enzyme: y µl H20 (up to final volume of 30 µl) 10X NEBuffer 4, 10 mM ATP with 1 µg of φX174 RF I DNA in NEBuffer 4 and 1 µl Exonuclease V (10 units) 1 mM ATP for 4 hours at 37°C resulted in < 10% M0345S Reaction Conditions: 1X NEBuffer 4 loss in φX174 RF I DNA as determined by agarose 1. Incubate at 37°C for 30 minutes. 2. To stop reaction add EDTA to 11 mM. 1,000 units 10,000 U/ml Lot: 0011210 supplemented with 1 mM ATP. Incubate at 37°C. gel electrophoresis. 3 Heat Inactivation 70°C for 30 minutes. RECOMBINANT Store at –20°C Exp: 10/14 1X NEBuffer 4: Endonuclease Activity II: Incubation of a 50 µl 4.
    [Show full text]
  • In Vitrocytotoxicity of Ranpirnase (Onconase)
    Postepy Hig Med Dosw (online), 2013; 67: 1166-1172 www.phmd.pl e-ISSN 1732-2693 Original Article Received: 2013.06.09 Accepted: 2013.10.13 In vitro cytotoxicity of ranpirnase (onconase) Published: 2013.12.02 in combination with components of R-CHOP regimen against diffuse large B cell lymphoma (DLBCL) cell line* Działanie cytotoksyczne onkonazy w skojarzeniu z lekami schematu R-CHOP na komórki linii chłoniaka rozlanego z dużych komórek B (DLBCL)* Agata Majchrzak1, , , , , , Magdalena Witkowska1,2, , , , Aleksandra Authors’ Contribution: Mędra1, , , Małgorzata Zwolińska1,2, , , , Jakub Bogusz1, , Barbara Study Design Cebula-Obrzut1, , , , , Zbigniew Darzynkiewicz3, , , Tadeusz Robak2, , , , Data Collection 1, , , , , , Statistical Analysis Piotr Smolewski Data Interpretation Manuscript Preparation 1 Department of Experimental Hematology and Literature Search 2 Department of Hematology, Medical University of Lodz, Poland, Funds Collection 3 The Brander Cancer Research Institute, New York Medical College, Valhalla, NY, USA Summary Ranpirnase (onconase; ONC) is an endoribonuclease obtained from the frog Rana pipiens. This enzyme exhibits anticancer properties mediated by degradation of cellular RNA and induction of apoptosis. In this study we assessed cytotoxicity of ONC in combination with currently used anticancer drugs on a human diffuse large B-cell lymphoma (DLBCL)-derived cell line (Toledo). Cytotoxic activity was measured by the exclusion of propidium iodide assay while apoptosis was assessed using the annexin-V binding method. Additionally, flow cytometry was used to assess the decline of mitochondrial potential and to determine activation of caspases 3, 8 and 9. It was observed that in vitro treatment with ONC in combination with rituximab, mafosfa- mide, vincristine, doxorubicin, and dexamethasone (drugs corresponding with elements of R-CHOP regimen) resulted in increased cytotoxicity.
    [Show full text]
  • Complete Genome of the Cellulolytic Thermophile Acidothermus Cellulolyticus 11B Provides Insights Into Its Ecophysiological and Evolutionary Adaptations
    Downloaded from genome.cshlp.org on October 2, 2021 - Published by Cold Spring Harbor Laboratory Press Letter Complete genome of the cellulolytic thermophile Acidothermus cellulolyticus 11B provides insights into its ecophysiological and evolutionary adaptations Ravi D. Barabote,1,9 Gary Xie,1 David H. Leu,2 Philippe Normand,3 Anamaria Necsulea,4 Vincent Daubin,4 Claudine Me´digue,5 William S. Adney,6 Xin Clare Xu,2 Alla Lapidus,7 Rebecca E. Parales,8 Chris Detter,1 Petar Pujic,3 David Bruce,1 Celine Lavire,3 Jean F. Challacombe,1 Thomas S. Brettin,1 and Alison M. Berry2,10 1DOE Joint Genome Institute, Bioscience Division, Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA; 2Department of Plant Sciences, University of California, Davis, California 95616, USA; 3Centre National de la Recherche Scientifique (CNRS), UMR5557, E´cologie Microbienne, Universite´ Lyon I, Villeurbanne F-69622, France; 4Centre National de la Recherche Scientifique (CNRS), UMR5558, Laboratoire de Biome´trie et Biologie E´volutive, Universite´ Lyon I, Villeurbanne F-69622, France; 5Centre National de la Recherche Scientifique (CNRS), UMR8030 and CEA/DSV/IG/Genoscope, Laboratoire de Ge´nomique Comparative, 91057 Evry Cedex, France; 6National Renewable Energy Laboratory, Golden, Colorado 80401, USA; 7DOE Joint Genome Institute, Walnut Creek, California 94598, USA; 8Department of Microbiology, University of California, Davis, California 95616, USA We present here the complete 2.4-Mb genome of the cellulolytic actinobacterial thermophile Acidothermus cellulolyticus 11B. New secreted glycoside hydrolases and carbohydrate esterases were identified in the genome, revealing a diverse biomass- degrading enzyme repertoire far greater than previously characterized and elevating the industrial value of this organism.
    [Show full text]
  • Lp16-PSP, a Member of Yjgf/Yer057c/UK114 Protein
    Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 25 September 2017 doi:10.20944/preprints201709.0119.v1 Peer-reviewed version available at Int. J. Mol. Sci. 2017, 18, 2407; doi:10.3390/ijms18112407 1 Article 2 Lp16-PSP, a member of YjgF/YER057c/UK114 Protein 3 Family Induces Apoptosis and p21WAF1/CIP1 mediated G1 4 Cell Cycle Arrest in Human Acute Promyelocytic 5 Leukemia (APL) HL-60 Cells 6 Thomson Patrick Joseph1†, Warren Chanda1†, Abdullah Faqeer Muhammad2, Sadia Kanwal3, Samana 7 Batool1, Meishan Zhang1, MinTao Zhong1 and Min Huang1* 8 1Department of Microbiology, College of Basic Medical Sciences, Dalian Medical University, Dalian, Liaoning 116044, 9 China 10 2Institute of Cancer Stem Cell, Dalian Medical University, Dalian, Liaoning 116044, China 11 3Department of Biotechnology, College of Basic Medical Sciences, Dalian Medical University, Dalian, Liaoning, China 12 †Contributed Equally 13 *Corresponding Author: [email protected]; +8641186110304 14 Abstract: 15 Lp16-PSP from Lentinula edodes strain C91-3 has been reported previously in our laboratory to have selective 16 cytotoxic activity against a panel of human cell lines. Herein, we have used several parameters in order to 17 characterize the Lp16-PSP-induced cell death using HL-60 as model cancer. The results of phase contrast 18 microscopy, nuclear examination, DNA fragmentation detection and flow cytometry revealed that high 19 doses of Lp16-PSP resulted in the induction of apoptosis in HL-60 cells. The colorimetric assay showed the 20 activation of caspase-8, -9 and -3 cascade highlighting the involvement of Fas/FasL-related pathway. 21 Whereas, western blot revealed the cleavage of caspase-3, increased expression of Bax, the release of 22 cytochrome c and decreased expression of Bcl-2 in a dose-dependent manner, suggesting the intrinsic 23 pathway might be involved in Lp16-PSP-induced apoptosis either.
    [Show full text]
  • Specificity of Escherichia Coli Endoribonuclease Rnase E: in Vivo and in Vitro Analysis of Mutants in a Bacteriophage T4 Mrna Processing Site
    Downloaded from genesdev.cshlp.org on October 6, 2021 - Published by Cold Spring Harbor Laboratory Press specificity of Escherichia coli endoribonuclease RNase E: in vivo and in vitro analysis of mutants in a bacteriophage T4 mRNA processing site Claude P. Ehretsmann/ Agamemnon J. Carpousis,^ and Henry M. Krisch^ Department of Molecular Biology, University of Geneva, 1211 Geneva 4, Switzerland Endoribonuclease RNase £ has an important role in the processing and degradation of bacteriophage T4 and Escherichia coli mRNAs. We have undertaken a mutational analysis of the -71 RNase E processing site of T4 gene 32. A Series of mutations were introduced into a synthetic T4 sequence cloned on a plasmid, and their effects on processing were analyzed in vivo. The same mutations were transferred into T4 by homologous recombination. In both the plasmid and the phage contexts the processing of the transcripts was similarly affected by the mutations. Partially purified RNase E has also been used to ascertain the effect of these mutations on RNase E processing in vitro. The hierarchy of the efficiency of processing of the various mutant transcripts was the same in vivo and in vitro. These results and an analysis of all of the known putative RNase E sites suggest a consensus sequence RAUUW (R = A or G; W ^ A or U) at the cleavage site. Modifications of the stem-loop structure downstream of the -71 site indicate that a secondary structure is required for RNase E processing. Processing by RNase E was apparently inhibited by sequences that sequester the site in secondary structure. [Key Words: Bacteriophage T4 gene 32; mRNA degradation; RNA processing; ribonuclease E] Received August 29, 1991; revised version accepted November 14, 1991.
    [Show full text]